Flow Cytometry-Based Test for HPV Receives CE Mark

IncellDx received a CE Mark for its HPV OncoTect 3Dx flow cytometry assay for human papillomavirus. The assay enables women to go beyond cervical cancer screening tests in determining if they are infected with a high-risk strain of HPV.

The test provides results in four hours, including the quantification of oncogene mRNA overexpression, proliferation and abnormal numbers of chromosomes.

The assay enables the identification of ectocervical cells and quantifies the percentage of cells that overexpress E6 and E7 mRNA.